logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: tissue-engineering
Load new posts () and activity
Like Reblog Comment
text 2019-11-19 11:04
Tissue Engineering Market 2019: Industry Analysis, Global Overview, Emerging Trends

Tissue Engineering Market Analysis

The global tissue engineering market is poised to grow at a healthy 17.22% CAGR over the estimated years (2017-2022). Tissue engineering simply put, is the utilization of combination of engineering materials, suitable biochemical factors and cells to replace or augment biological functions for repairing damaged organs and tissues. It is a method of biomaterial development combining biologically active molecules, cells and scaffolds into functional tissues. Tissue engineering creates functional constructs which restore, improve or maintain whole organs or damaged tissues. It can replace the presently used tissue repair solutions such as mechanical devices, surgical reconstruction and transplants. Tissue engineering has a couple of key application segments including neurology, cardiology and vascular, spine, orthopedics, musculoskeletal, urology, dental, skin or integumentary, GI and gynecology, cord blood and cell banking and cancer.

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2134

 

There are numerous factors that is driving the growth of the tissue engineering market. These factors according to MRFR (Market Research Future) report include increasing cases of road accidents, trauma injuries and chronic diseases, increasing government funding and initiatives for ongoing tissue regeneration research, recent technological advancements namely use of nanotechnology in the process of tissue regeneration and 3D tissue engineering and increasing prevalence of cancer. On the contrary, stringent regulations for approvals, high price of tissue engineering treatment, time taking method to develop tissues, and concerns associated to hidden diseases or illness in the base tissue are some factors that may deter the tissue engineering market growth over the estimated years.

 

Tissue Engineering Market Segmentation

MRFR report offers a complete segmental analysis of the tissue engineering market on the basis of materials and applications.

 

Based on materials, it is segmented into nano-composite material, composite materials, nano-fibrous materials and biomimetic materials. Of these, nano-fibrous segment will dominate the tissue engineering market over the estimated years.

Based on applications, tissue engineering market is segmented into GI and gynecology, cord blood and cell banking, neurology, urology, cardiology, dental, cancer, skin/integumentary and orthopedics, musculoskeletal and spine. Of these, orthopedics, musculoskeletal and spine will have the maximum share in the market over the estimated years.

 

Regional Analysis

By region, the tissue engineering market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and the Middle East and Africa. Of these, North America will have an edge over others during the estimated years. The factors can be attributed to growing developments in regeneration surgeries, especially stem cell research that has opened new opportunities, existence of global market players and constant technological development methods. The tissue engineering market in Europe will hold the second major share owing to accessibility of funds for R&D activities, increasing support from the government for life science sector and industries that are constantly focusing and also upgrading 3D technology that is offering enhanced and better tissue and organ printing methods.

 

In the APAC region, the tissue engineering market will grow at the fastest pace over the estimated years owing to improved economic situations in the healthcare sector, more focus by the government on R&D in the healthcare domain, increasing use of technological development in the healthcare domain leading to improvement in healthcare facilities which is projected to fuel the market in this region over the estimated years. On the other hand, the tissue engineering market in the Middle East and Africa is projected to have limited growth owing to less encouragement in the healthcare sector from the government, dearth of advanced medical facilities and limited access to healthcare resources.

 

Tissue Engineering Market Key Players

Leading players profiled in the tissue engineering market include Stryker, Zimmer Inc., Medtronic, DePuy Synthes Companies, Baxter, Acelity and Cook.

 

Browse Complete Report with TOC at https://www.marketresearchfuture.com/reports/tissue-engineering-market-2134

 

Tissue Engineering / Regeneration Companies News March 2019- The Department of Biomedical Engineering in UCI are coming up with a tissue engineering approach for TMJ disorders. They are creating biological TMJ discs which will be ideal for human implantation. The end product which they aspire to use to treat the TMJ disc afflictions is a product that is tissue-engineered which is fully biological, alive and mechanically comparable with the real thing.

 

Source: www.marketresearchfuture.com/reports/tissue-engineering-market-2134
Like Reblog Comment
text 2019-11-12 06:46
How Biomaterials is Revolutionizing the Global Healthcare Industry

Emerging markets such as China, India, and Japan are the key areas of opportunity for players in this market. However, stringent clinical & regulatory processes and unfavorable healthcare reforms in the US are expected to restrain the growth.

 

Increased funds and grants by government bodies and universities for the

development of novel biomaterials

 

The demand for and usage of biomaterials in various medical applications has increased significantly across the globe over the last few years. Also, several government bodies and universities have extended their help in the form of investments, funds, and grants to promote research into the development of novel biomaterials.

 

Stringent clinical & regulatory processes

 

Biomaterial-based medical devices are stringently regulated in several regions, including North America, Europe, and Asia, to ensure their quality and efficacy. This is primarily attributed to the fact that most biomaterial-based medical devices are implantable. All new biomaterials require proof that they are safe and effective before they can be approved for marketing. In the US, the process for approval follows strict guidelines and regulations set by the FDA. According to the FDA, biomaterial-based products such as implantable pacemakers, stents, and heart valves are classified as Class III devices, which pose the highest potential risk of illness or injury. Thus, these devices are subjected to the premarket approval application pathway (which is the most stringent type of device marketing application).

 

The development of biomaterials involves time-consuming processes and expensive clinical trials. As these products have to be implanted inside the human body, they need to be biocompatible and have to undergo the ISO biocompatibility testing standards. However, it is difficult to anticipate the biocompatibility until the later stages of clinical trials, making companies and investors apprehensive of investing in this market. In addition, regulatory procedures are complicated, restrictive, and depend on biomaterial composition and future application. These factors are expected to restrain market growth to a certain extent in the coming years.

 

Shortage of skilled surgeons

 

According to the Lancet Commission on Global Surgery, ~2.2 million more surgeons, anesthetists, and obstetricians are required in low- and middle-income countries (LMICs) each year. Also, major healthcare markets such as the US, Germany, and the UK are witnessing a dearth of surgeons in their respective healthcare systems. For instance, according to the Association of American Medical Colleges, a deficit of 41,000 general surgeons is estimated in the US by 2025. Similarly, Ohio State University has projected that there would be about 3,000 cardiothoracic surgeons available to cover about 854,000 cases by 2030. Similarly, in the UK, there is 1 vascular surgeon per 137,000 individuals (Source: Survey conducted by the Vascular Society of Great Britain & Ireland in 2016).

 

The significant shortage of surgeons available to handle the increasing demand for procedures is expected to affect the uptake of implantable devices in the coming years. This is considered as a major challenge for the growth of the biomaterials market.

 

Key Market Players

 

Prominent players in the market are Royal DSM (Netherlands), BASF SE (Germany), Corbion (Netherlands), Carpenter Technology Corporation (US), Evonik Industries (Germany), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), Celanese Corporation (US), CoorsTek Inc. (US), CeramTec (Germany), and GELITA AG (Germany).

 

Royal DSM offers coatings, drug delivery platforms, and a wide range of biomedical materials, such as bioceramics, biomedical polyethylenes, biomedical polyurethanes, collagens, and ophthalmic biomaterials for various applications, such as orthopedics, sports medicine, ophthalmology, general surgery, and cardiology. The company offers polyethylenes under the brand names—Dyneema Purity Woven, Dyneema Purity Black Fiber, Dyneema Purity Radiopaque Fiber, Dyneema Purity SGX Fiber, Dyneema Purity TG Fiber, Dyneema Purity UG / VG Fiber, and Dyneema Purity Membrane.

 

 

Source: www.marketsandmarkets.com/Market-Reports/biomaterials-393.html
Like Reblog Comment
text 2019-10-04 07:53
Tissue Engineering Market Poised to Reach USD 53,424.00 Million by 2024

Market Research Future has Published a Cooked Research Report on the Global Tissue Engineering Market.

 

Market Highlights

The Global Tissue Engineering Market is estimated to be valued at USD 53,424.00 Million by 2024 and is expected to register a CAGR of 17.84% during the forecast period.

 

The nano-fibrous material segment dominated the global tissue engineering market, by material, and is projected to reach USD 16,235.5 Million by 2024 owing to the cost-effectiveness of the product; moreover. However, the biomimetic material segment is projected to be the fastest-growing segment during the forecast period.

 

North America dominated the market, accounting for the largest share of the market in 2018, and the regional market is expected to register a CAGR of 17.17% during the review period. The European market was the second largest in 2018. The market is projected to reach USD 16,514.6 million by the end of 2024.   

 

Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2134

 

Segment Analysis

The global tissue engineering market has been segmented based on material, application, and region. On the basis of material, the market has been divided into nano-fibrous material, biomimetic material, composite material. The nano-fibrous material segment held the majority market share in 2018. However, the biomimetic material segment is anticipated to be the fastest-growing, followed by the composite material segment.

 

On the basis of application, the market has been divided into orthopedics, musculoskeletal and spine, cancer, skin/integumentary, dental, cardiology, urology, neurology, cord blood & cell banking, GI & gynecology. The orthopedics, musculoskeletal and spine segment accounted for the larger market share in 2018. However, the cancer segment is expected to exhibit higher CAGR during the forecast period.

 

Market Players

Market Research Future (MRFR) recognizes Stryker (US), Allergan (US), Medtronic (Ireland), Zimmer (US), Baxter International (US), Integra Life Sciences (US), Organovo Holdings Inc (US), Cook Medical (US), DePuy Synthes (US), Acelity (US) as the key players in the Global Tissue Engineering Market.

 

Regional Analysis

Geographically, the global tissue engineering market has been segmented into North America, Europe, Asia-Pacific, and the rest of the world. As per MRFR analysis, North America was the largest market for tissue engineering in 2018 and is expected to remain dominant during the review period. Europe accounted for a significant market share and is projected to be the second-largest market during the forecast period. The rising prevalence of chronic diseases is a major driving factor for the growth of the tissue engineering market in Europe.

 

Key Findings of the Study:

  • The Global Tissue Engineering Market is projected to reach over USD 53,424.00 million by 2024 at a 84% CAGR during the review period of 2019 to 2024.
  • North America accounted for the largest market share.
  • The nano-fibrous material segment is projected to register the highest CAGR of 18.08% during the forecast period.
  • Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies. Moreover, they are focusing on e-commerce for distribution.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/tissue-engineering-market-2134

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

 

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Like Reblog Comment
text 2018-09-26 14:09
North America Dominated the Global Tissue Engineering Market in 2015

26 September 2018, The global Tissue Engineering Market was valued to be around USD 23.2 billion in 2015 and further expected to exceed USD 94.7 billion at a growing of CAGR 23% over the foreseeable period. Growing needs to bridge the gap between organ demand & supply are expected to drive the industry demand in the near future. Growing popularity in a variety of sectors including urological products, neurology, burn treatment etc. is also anticipated to boost the market growth. Organs developed using this method have high efficiency and durability. Rising applications of this method from surgical treatment of tissues and prosthetics to liver, corneal, cardiac tissue engineering is said to propel the growth from 2016 to 2024. The global market is categorized as applications and regions.

 

The applications include GI & gynecology, cancer, cord blood & cell banking, skin or integumentary, urology, dental, musculoskeletal, spine, orthopedics, neurology, and cardiology & vascular. The orthopedic application sector occupied more than half of the total market share in 2015. The sector is further expected to continue leading the market on account of the increased number of bone implants due to accidents as well as a geriatric population base. The neurology sector is one of the fastest-growing application sectors since it has the wider scope for development. In addition to this, a significant amount of research in the neurology sector is also anticipated to drive the sector growth.

 

Browse Details of Report @ https://www.hexaresearch.com/research-report/tissue-engineering-market

 

Regionally, North America dominated the global tissue engineering market in 2015 accounting for the largest share. It is further projected to continue its dominance even during the forecast period. This can be attributed to the presence of leading players in the region and high financial support for R&D from the government as well as some private organizations. The Asia-Pacific region is expected to be the most lucrative region in the near future. This is mainly because of the existence of immense manpower and highly developed procedures coupled with government funding. The European market is said to register reasonable growth prospects due to the presence of stringent regulatory rules.

 

Major players in the tissue engineering market are acquiring and working in partnerships with small-scale companies so as to influence technology & research advancements and to expand the product portfolio. Some of the key players include Sanofi S. A.; CryoLife Inc.; StemCells Inc.; and BioMimetic Therapeutics Inc.

 

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

More posts
Your Dashboard view:
Need help?